This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Preliminary Report

J. S. HORAN, M.D.

Arch Intern Med. 1950;85(6):972-979.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

DURING the last eight years numerous reports have been published on the intravenous use of procaine (novocain^®) hydrochloride. In the United States interest has centered mainly on administration in the slow intravenous drip of 0.1 and 0.2 per cent solutions, taking from twenty minutes to an hour and a half. Results have been excellent in the treatment of many traumatic conditions, inflammatory states and pain syndromes. Unfortunately, however, the giving of an infusion of 500 cc. of solution by slow intravenous drip is not practical in a physician's office. It seemed advisable to search for a more potent solution that could be given quickly in small doses. Workers in Europe have reported on the use of 1 per cent solution of procaine hydrochloride intravenously, with good results. It has been given in treatment of asthma,¹ angina pectoris^lb and numerous other conditions, usually in doses of 3 to . . . [Full Text PDF of this Article]

Author Affiliations
MEMPHIS, TENN.

From the Department of Psychiatry and Neurology, College of Medicine, University of Tennessee.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?